Form 4 Tracker
Revolution Medicines, Inc.
RVMD

55 insider filings · Latest: Sep 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 18, 2025Nov 18 9:23 PMMARK A GOLDSMITH
Proposed Sale
20,000$69.14$1.4M—

View →

Nov 18, 2025Nov 18 9:23 PMJEFFREY TODD CISLINI
Proposed Sale
13,388$69.14$925.6K—

View →

Nov 12, 2025Nov 12 9:40 PMMARK A GOLDSMITH
Proposed Sale
20,000$64.08$1.3M—

View →

Nov 11, 2025Nov 12 12:04 PMJACK LEE ANDERS
Proposed Sale
10,000$62.73$627.3K—

View →

Nov 7, 2025Nov 7 9:38 PMMARK A GOLDSMITH
Proposed Sale
30,000$61.38$1.8M—

View →

Oct 17, 2025Oct 17 8:18 PMMARK A GOLDSMITH
Proposed Sale
10,000$49.68$496.8K—

View →

Oct 17, 2025Oct 17 8:17 PMJEFFREY TODD CISLINI
Proposed Sale
12,000$49.68$596.2K—

View →

Oct 16, 2025Oct 16 8:21 PMMARK A GOLDSMITH
Proposed Sale
10,000$49.56$495.6K—

View →

Sep 24, 2025Sep 24 8:21 PMJEFFREY TODD CISLINI
Proposed Sale
1,799$44.21$79.5K—

View →

Sep 15, 2025Sep 16 1:32 AMWei Lin
Proposed Sale
2,131$46.55$99.2K—

View →

Sep 15, 2025Sep 16 1:28 AMKelsey Stephen Michael
Proposed Sale
5,296$46.55$246.5K—

View →

Sep 15, 2025Sep 16 1:24 AMHorn Margaret A
Proposed Sale
4,712$46.55$219.3K—

View →

Sep 15, 2025Sep 16 1:20 AMGOLDSMITH MARK A
Proposed Sale
13,236$46.55$616.1K—

View →

Sep 15, 2025Sep 16 1:18 AMCislini Jeff
Proposed Sale
1,842$46.55$85.7K—

View →

Sep 15, 2025Sep 16 1:14 AMAnders Jack
Proposed Sale
2,128$46.55$99.1K—

View →

Sep 11, 2025Sep 11 8:30 PMSTEPHEN M. KELSEY
Proposed Sale
150,000$40.45$6.1M—

View →

Sep 2, 2025Sep 2 8:41 PMJACK LEE ANDERS
Proposed Sale
10,000$37.97$379.7K—

View →

Jun 20, 2025Jun 20 8:23 PMJEFFREY TODD CISLINI
Proposed Sale
1,912$39.93$76.3K—

View →

Jun 16, 2025Jun 13 9:25 PMWei Lin
Proposed Sale
2,131$40.79$86.9K—

View →

Jun 16, 2025Jun 13 9:05 PMKelsey Stephen Michael
Proposed Sale
3,732$40.79$152.2K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 29, 2026Oct 1 10:00 PMAlan B. SandlerChief Development Officer
Option Exercise
6,000$58.84161,300(D)

View →

Sep 25, 2026Sep 28 10:00 PMAnthony ManciniChief Global Commercialization Officer
Option Exercise
3,121$33.6293,625(D)

View →

Sep 22, 2026Sep 24 10:00 PMElizabeth M AndersonDirector
Option Exercise
5,070$1.121,095(D)

View →

Sep 11, 2026Sep 15 10:00 PMStephen Michael KelseySenior Advisor to the Chief Executive Officer
Option Exercise
92,531$42.4588,069(D)

View →

Sep 10, 2026Sep 14 10:03 PMAnthony ManciniChief Global Commercialization Officer
Option Exercise
9,363$33.6296,746(D)

View →

Aug 21, 2026Aug 25 8:06 PMJeff CisliniGeneral Counsel
Option Exercise
56,280$21.613,500(D)

View →

Aug 21, 2026Aug 25 8:06 PMMark A GoldsmithDirector, President and Chief Executive Officer
Option Exercise
80,000$4.73344,085(D)

View →

Jun 29, 2026Jul 1 10:25 PMSushil PatelDirector
Option Exercise
2,955$37.5413,000(D)

View →

Jun 24, 2026Jun 26 8:10 PMJack AndersChief Financial Officer
Option Exercise
20,000$18.5620,600(D)

View →

Jun 18, 2026Jun 23 9:57 PMLorence H. KimDirector
Grant/Award
3,127$162.993,127(D)

View →

Jun 18, 2026Jun 23 9:52 PMAlexis BorisyDirector
Grant/Award
3,127$162.993,127(D)

View →

Jun 18, 2026Jun 23 9:45 PMElizabeth M AndersonDirector
Grant/Award
3,127$162.993,127(D)

View →

Jun 18, 2026Jun 23 9:45 PMSandra HorningDirector
Grant/Award
3,127$162.993,127(D)

View →

Jun 18, 2026Jun 23 9:44 PMFrank ClyburnDirector
Grant/Award
3,127$162.993,127(D)

View →

Jun 18, 2026Jun 23 9:43 PMSushil PatelDirector
Grant/Award
3,127$162.993,127(D)

View →

Jun 18, 2026Jun 23 9:42 PMFlavia BorelliniDirector
Grant/Award
3,127$162.993,127(D)

View →

Jun 17, 2026Jun 17 11:51 PMMargaret A HornChief Operating Officer
Option Exercise
29,600$40.74114,275(D)

View →

Jun 15, 2026Jun 17 11:51 PMMargaret A HornChief Operating Officer
Option Exercise
60,400$40.7475,052(D)

View →

Jun 11, 2026Jun 15 8:05 PMMargaret A HornChief Operating Officer
Option Exercise
10,000$42.4591,194(D)

View →

May 26, 2026May 28 8:10 PMAnthony ManciniChief Global Commercialization Officer
Option Exercise
3,121$33.62106,109(D)

View →

Page 1 of 2

Next →